AMANDA ROBINSON: Open Payments
NPI 1184139479 · MAQUOKETA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 15 payments from 10 companies in 2025. Trend: 2023 $29 · 2024 $375 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| Lilly USA, LLC | 2 | $48 |
| Novo Nordisk Inc | 2 | $38 |
| Exact Sciences Corporation | 2 | $35 |
| ABBVIE INC. | 1 | $33 |
| Dynavax Technologies Corporation | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Amgen Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: JARDIANCE, Cologuard Collection Kit, UBRELVY, Heplisav-B, PEDIARIX, REPATHA, MOUNJARO, Wegovy.
Industry payments across IA — which companies pay providers there.
